RxDoctor Payments Data

Brian Badman, MD

Orthopaedic Surgery · Fishers, INNPI 1801848783

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $550,441 of the $591,192 with a category attached, or 93.1%. Encore Medical, LP accounts for 90.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $111,720 and has fallen 56.2% since, to $48,879 in 2025. Among orthopaedic surgery clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$591,192in general payments, 2019–2025

Across 384 payments — averaging $1539.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$537K
  • Insight Medical Systems, Inc.$18K
  • Anika Therapeutics, Inc.$13K
  • Embody, Inc.$10K
  • Shoulder Innovations, Inc.$7K
  • Restor3d, Inc.$4K
  • plus $3K from 10 others
$131,829in research payments, 2019–2025

Across 23 payments — averaging $5731.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$78K
  • Anika Therapeutics, Inc.$38K
  • Bone Support Inc.$10K
  • Arthrex$6K
$1,006in ownership & investment interests, 2019–2025

Across 1 payment — averaging $1006.47 each. An ownership or investment interest held by the physician or an immediate family member.

  • Restor3d, Inc.$1K

What the payments were for

  • Consulting fees$550,44193%
  • Travel & lodging$31,6575%
  • Food & beverage$7,8781%
  • Education$1,2000%
  • Entertainment$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$591,192 in reported general payments places this provider in the 95th percentile of 400 orthopaedic surgery providers in Indiana.

See all orthopaedic surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$283,470
Medicare patients
449
Services billed
4,023

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib11$1,953
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$517
Oxycodone Hcl47$196
Ondansetron OdtOndansetron14$148
Hydroxyzine Pamoate19$137
Tramadol Hcl30$113
Ampicillin Trihydrate37$80
Methylprednisolone12$59
Tizanidine Hcl13$58

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Fishers

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →